Vaccine effectiveness and duration of protection of Comirnaty, Vaxzevria and Spikevax against mild and severe COVID-19 in the UK

Nick Andrews, Elise Tessier, Julia Stowe, Charlotte Gower, Freja Kirsebom, Ruth Simmons, Eileen Gallagher, Meera Chand, Kevin Brown, Shamez N Ladhani, Mary Ramsay, Jamie Lopez Bernal
doi: https://doi.org/10.1101/2021.09.15.21263583

Article usage

Article usage: September 2021 to November 2024

AbstractFullPdf
Sep 20214221861261
Oct 2021634812901874
Nov 20211880215015555
Dec 2021101299844541
Jan 202266985171250
Feb 20223187243478
Mar 20222724235355
Apr 20222043172310
May 2022149469213
Jun 2022138645147
Jul 202291594152
Aug 202278651154
Sep 202285130101
Oct 202276387118
Nov 20225714880
Dec 20223812389
Jan 20233903495
Feb 20232852077
Mar 20233283862
Apr 20232712759
May 20232201738
Jun 20232542130
Jul 20232732032
Aug 20232231838
Sep 20233043434
Oct 20232662768
Nov 20232664034
Dec 20232191737
Jan 20243822051
Feb 20241751848
Mar 202417524102
Apr 20242123264
May 20241941567
Jun 20241821937
Jul 20242032262
Aug 20241503046
Sep 20241832271
Oct 20241521235
Nov 2024501
Back to top
Posted September 21, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Vaccine effectiveness and duration of protection of Comirnaty, Vaxzevria and Spikevax against mild and severe COVID-19 in the UK
Nick Andrews, Elise Tessier, Julia Stowe, Charlotte Gower, Freja Kirsebom, Ruth Simmons, Eileen Gallagher, Meera Chand, Kevin Brown, Shamez N Ladhani, Mary Ramsay, Jamie Lopez Bernal
medRxiv 2021.09.15.21263583; doi: https://doi.org/10.1101/2021.09.15.21263583
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area